Yahoo
BSE - Delayed Quote INR

Neuland Laboratories Limited (NEULANDLAB.BO)

20,323.05 +446.25 (+2.25%)
At close: 3:29:59 PM GMT+5:30
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
23,071,936 19,321,190 14,343,821 15,156,631 11,608,985
Cost of Revenue
-10,424,523 -9,471,166 -7,505,080 -7,337,967 -6,137,853
Gross Profit
12,647,413 9,850,024 6,838,741 7,818,664 5,471,132
Selling, General and Administrative Expenses
-3,954,919 -4,282,232 -3,363,004 -3,132,462 -2,634,523
Depreciation, Amortization and Depletion
-1,043,430 -917,395 -655,466 -596,999 -527,774
Taxes Other Than Income Taxes
-76,353 -76,353 -56,167 -80,719 -46,652
Provision Expense/Write-Back
19,915 19,915 -1,467 40,358 -8,850
Other Income/Expense, Operating
-1,643,340 306,277 -96,860 24,980 90,081
Operating Income/Expenses
-6,641,689 -4,949,788 -4,172,964 -3,744,842 -3,127,718
Total Operating Profit/Loss
6,005,724 4,900,236 2,665,777 4,073,822 2,343,414
Total Net Finance Income/Expense
-282,746 -138,920 22,869 -57,706 -115,108
Net Investment Income
181,193 181,193 82,784 -552 -103,328
Irregular Income/Expenses
0 -52,738 691,860 -1,199 27,282
Other Income/Expense, Non-Operating
364,976 -- -- 0 5,204
Non-Operating Income/Expenses, Total
82,230 -10,465 797,513 -59,457 -185,950
Pretax Income
6,087,954 4,889,771 3,463,290 4,014,365 2,157,464
Provision for Income Tax
-1,562,528 -1,249,787 -862,209 -1,013,576 -522,288
Net Income from Continuing Operations
4,525,426 3,639,984 2,601,081 3,000,789 1,635,176
Net Income after Extraordinary Items and Discontinued Operations
4,525,426 3,639,984 2,601,081 3,000,789 1,635,176
Net Income after Non-Controlling/Minority Interests
4,525,426 3,639,984 2,601,081 3,000,789 1,635,176
Net Income Available to Common Stockholders
4,525,426 3,639,984 2,601,081 3,000,789 1,635,176
Diluted Net Income Available to Common Stockholders
4,525,426 3,639,984 2,601,081 3,000,789 1,635,176
Common Dividend per Share
34.00 34.00 12.00 14.00 10.00
Basic EPS
352.72 283.71 202.74 233.89 127.45
Diluted EPS
352.72 283.71 202.74 233.89 127.45
Basic Weighted Average Shares Outstanding
12,829.48 12,829.89 12,829.89 12,829.89 12,829.89
Diluted Weighted Average Shares Outstanding
12,829.48 12,829.89 12,829.89 12,829.89 12,829.89
Income Statement, Supplemental
EBIT
6,370,700 4,976,184 3,415,344 4,042,841 2,245,916
EBITDA
7,414,130 5,893,579 4,070,810 4,639,840 2,773,690
3/31/2023 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: